Psychometric Properties of the Montreal Cognitive Assessment (MoCA) in Parkinson's Disease Patients in Isfahan

Document Type : Original Article (s)

Authors

1 Department of Psychology, School of Educational Sciences and Psychology, The University of Isfahan, Isfahan, Iran

2 Professor, Department of Psychology, School of Educational Sciences and Psychology, The University of Isfahan, Isfahan, Iran

3 Associate Professor, Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Assistant Professor, Department of Psychology, School of Educational Sciences and Psychology, The University of Isfahan, Isfahan, Iran

Abstract

Background: The montreal cognitive assessment (MoCA) is a screening tool for evaluating mild cognitive impairments. The purpose of this research was to study the psychometric properties of the MoCA in Parkinson's disease patients in Isfahan, Iran.Methods: Thirty-five patients with Parkinson’s disease who satisfied all the inclusion criteria were referred to the researchers by a neurologist. They answered the MoCA, and the mini mental status examination (mmse) and demographic questionnaires. In addition, 40 healthy subjects with all the inclusion criteria except Parkinson's disease were randomly selected. They also completed the scales. Cronbach's alpha, Pearson correlation, and discriminant analysis were respectively used for computing reliability, concurrent validity, and diagnostic validity of the test.Findings: A Cronbach's alpha of 0.77, concurrent validity of 0.79, sensitivity of 0.85 and specificity of 0.90 were found. ROC table revealed 24 as the best cut-off point for MoCA.Conclusion: MoCA can be a valid and reliable instrument for assessing cognitive deficits in Iranian Parkinson's disease patients.

Keywords

References

  1. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256(3): 183-94.
  2. Sarvar AI, Trail M, Lai EC. Cognitive impairments associated with parkinson's disease. In: Trail M, Protas E, Lai E, editors. Neurorehabilitation in Parkinson's disease: an evidence-based treatment model.USA: SLACK Incorporated; 2008.
  3. Bassett SS. Cognitive impairment in Parkinson's disease. Primary Psychiatry 2005; 12(7): 50-5.
  4. Pagonabarraga J, Kulisevsky J, Llebaria G, Garcia-Sanchez C, Pascual-Sedano B, Gironell A. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease. Mov Disord 2008; 23(7): 998-1005.
  5. Howard C. Mild cognitive impairment. Current Opinion in Neurology 2002; 15(4): 401-7.
  6. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53(4): 695-9.
  7. Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, Wadia P, et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord 2008; 23(2): 297-9.
  8. Gill DJ, Freshman A, Blender JA, Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov Disord 2008; 23(7): 1043-6.
  9. Athilingam P. Validation of an instrument to measure cognitive function in patients with heart failure 2007.
  10. Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, et al. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc 2009; 57(2): 304-8.
  11. Wittich W, Phillips N, Nasreddine ZS, Chertkow H. Sensitivity and Specificity of the Montreal Cognitive Assessment Modified for Individuals Who Are Visually Impaired. Journal of Visual Impairment & Blindness 2010; 104(6): 360-8.
  12. Wong A, Xiong YY, Kwan PW, Chan AY, Lam WW, Wang K, et al. The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord 2009; 28(1): 81-7.
  13. Miller MD. Clinician's Guide to Interpersonal Psychotherapy in Late Life: Helping Cognitively Impaired or Depressed Elders and Their Caregivers. 1st ed. New York: Oxford University Press, USA; 2009.
  14. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189-98.
  15. Foroghan M, Jafari Z, Shirinbaian P, Ghaemmagham Farahani Z, Rahgozar M. Standardization brief examination of the cognitive status of elderly in Tehran. Advances in Cognitive Science 2008; 10(2): 29-37.
  16. Lezak MD. Neuropsychological assessment. 4th ed. New York: Oxford University Press; 2004.
  17. Tierney MC, Szalai JP, Snow WG, Fisher RH, Dunn E. Domain specificity of the subtests of the Mini-Mental State Examination. Arch Neurol 1997; 54(6): 713-6.
  18. Farber JF, Schmitt FA, Logue PE. Predicting intellectual level from the Mini-Mental State Examination. J Am Geriatr Soc 1988; 36(6): 509-10.
  19. Strauss E, Sherman EM, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. 3rd ed. New York: Oxford University Press; 2006.
  20. Smith T, Gildeh N, Holmes C. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry 2007; 52(5): 329-32.
Journal of Isfahan Medical School
Volume 29, Issue 158 - Serial Number 158
September and October 2011
Pages 1606-1615

Files

History

  • Receive Date: 26 July 2011
  • Revise Date:
  • Accept Date: 06 April 2022

Share

How to cite

Statistics